Cleared Traditional

K202620 - FlexCath Advance Steerable Sheath and D...

K202620 is the FDA 510(k) clearance for FlexCath Advance Steerable Sheath and D... by Medtronic Cryocath, LP. It is a Class 2 Cardiovascular device (product code DRA) cleared through the Traditional 510(k) pathway after a 64-day FDA review.

K202620 · Medtronic Cryocath, LP · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
64d
Days
Class 2
Risk

K202620 is an FDA 510(k) clearance for the FlexCath Advance Steerable Sheath and Dilator. Classified as Catheter, Steerable (product code DRA), Class II - Special Controls.

Submitted by Medtronic Cryocath, LP (Minneapolis, US). The FDA issued a Cleared decision on November 13, 2020 after a review of 64 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1280 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic Cryocath, LP devices

Submission Details

510(k) Number K202620 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2020
Decision Date November 13, 2020
Days to Decision 64 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 125d · This submission: 64d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRA Catheter, Steerable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1280
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRA Catheter, Steerable

All 15
Devices cleared under the same product code (DRA) and FDA review panel - the closest regulatory comparables to K202620.
MitraClip G4 Steerable Guide Catheter
K221397 · Abbott Medical · Sep 2022
AcQGuide® VUE Steerable Sheath
K221044 · Acutus Medical, Inc. · May 2022
AcQGuide MAX Steerable Sheath
K211100 · Acutus Medical, Inc. · May 2021
Steerable Introducer 12F
K192422 · Freudenberg Medical, LLC · Oct 2019
MitraClip G4 Steerable Guide Catheter
K190167 · Abbott · May 2019
FlexCath Advance Steerable Sheath and Dilator
K183174 · Medtronic Cryocath, LP · Nov 2018